Formulating
the Future,
Producing Success

Amaran Biotech, a leading Contract Development and Manufacturing Organization (CDMO) and advanced adjuvant provider, is continuing its commitment to quality excellence and operational efficiency through the implementation of a comprehensive electronic Quality Management System (eQMS), Simploud. This strategic move is designed to ensure the highest standards of product quality and patient safety, maintain rigorous regulatory compliance and audit readiness, enhance operational efficiency, reduce costs, and improve data integrity through paperless operation. Amaran Biotech is pleased to announce the successful rollout and go-live of the electronic Standard Operating Procedures (eSOP) module. This critical milestone signifies an important step in transitioning from […]

Amaran Biotech is pleased to announce our participation in the 7th Vaccine World Asia Congress 2025 – South East Asia, where we will introduce our proprietary AB-801(QS-21) vaccine adjuvant and share insights into how it accelerates vaccine commercialization. Presentation Details: Join us at this premier regional vaccine event to explore how Amaran Biotech addresses the QS-21 paradox and empowers partners with superior adjuvant technology for next-generation vaccine development. 🔗 Event Website: Vaccine World Asia Congress 2025 – South East Asia

Amaran Biotech will participate in BioJapan 2025 from October 8–10 at Pacifico Yokohama, together with BPIPO(Biotechnology and Pharmaceutical Industries Promotion Office), DCB(Development Center for Biotechnology), and fellow biotech companies from Taiwan. As one of Asia’s most influential biotech and pharma exhibitions, BioJapan brings together exhibitions, seminars, and partnering meetings, serving as a key platform for global collaboration. 📍 You can find us at the Taiwan Pavilion, Booth B-77.🤝 Book a meeting with us by searching “Amaran” on the BioJapan partnering platform, or contact us directly at service@amaranbiotech.com. We look forward to meeting our partners and exploring new opportunities in Yokohama.

In the pharmaceutical sector, the pathway from innovative science to successful commercialization is governed by two inseparable forces: Scientific Progress and Regulatory Integrity. At Amaran Biotech, our Quality Assurance philosophy is proactive and deeply integrated. We employ a Quality by Design (QbD) approach to establish our systems, building quality into our processes from the earliest stages. Our entire framework is meticulously structured to exceed global Good Manufacturing Practice (GMP) requirements, creating a robust and scalable process ready for large-scale production. Furthermore, our commitment extends to rigorous continuous improvement. Through robust data analysis and a disciplined Corrective and Preventive Action (CAPA) […]

Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was awarded the “Best Fill-Finish” at the 2025 Asia-Pacific Biologics CDMO Excellence Awards held in Singapore on September 10. This honor recognizes Amaran Biotech’s leading capabilities in aseptic fill-finish processes and marks an important step for Taiwan’s biotech industry on the international stage. The Asia-Pacific Biologics CDMO Excellence Awards, organized by the renowned international consulting firm IMAPAC, celebrate CDMOs in the region that have made outstanding contributions to biologics innovation and manufacturing. This year, Amaran Biotech was nominated for its achievements in supporting international clients with large-molecule drug fill-finish and […]